Oral Ulcer

Search with Google Search with Bing
Information
Disease name
Oral Ulcer
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00333749 Completed Phase 1 The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases January 2006 December 2007
NCT04383236 Completed N/A Probiotic Lozenges for Treatment of Recurrent Aphthous Stomatitis December 1, 2016 April 21, 2019
NCT05032248 Completed N/A Uses of Tacrolimus in Behcet Disease April 1, 2019 December 1, 2019
NCT05147376 Completed Early Phase 1 Effectiveness of a Curcumin Mouthwash in Preventing Traumatic Ulcers in Patients With Fixed Orthodontic Appliances February 21, 2022 August 7, 2023
NCT05413096 Completed Early Phase 1 Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis June 1, 2021 November 1, 2022
NCT06379438 Completed N/A Treatment of Aphtous Ulcers With Photodynamic Therapy March 5, 2018 March 8, 2019
NCT03167632 Completed Oral Ulcer Prevalence: Hospital-based Cross-sectional Study August 10, 2015 October 25, 2015
NCT03239834 Completed Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-Making September 7, 2017 December 20, 2020
NCT03633292 Completed Phase 4 Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers January 2015 January 2018
NCT05449548 Recruiting N/A Lenalidomide in the Treatment of Mucosal Behçet's Syndrome April 1, 2023 March 31, 2025
NCT04710888 Unknown status Phase 2 Basil Extract (Ocimum Basilicum) in the Management of Recurrent Aphthous Stomatitis January 1, 2021 December 1, 2021
NCT04989049 Unknown status Early Phase 1 Therapeutic Effect of Folic Acid in Healing of Oral Ulcers September 2022 December 2022
NCT05288478 Unknown status Phase 2 Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. April 6, 2022 March 2023
NCT02769494 Withdrawn Phase 3 The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer March 2016 January 2017
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0000155
MedGen concept unique identifier (MedGen Concept name)
C0149745
MedGen unique identifier (MedGen Concept name)
57699
MeSH unique ID (MeSH (Medical Subject Headings))
D019226